These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9824933)

  • 1. [Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy].
    Briceño Delgado FJ; López Cillero P; Rufián Peña S; Solórzano Peck G; Miño Fugarolas G; Pera Madrazo C
    Rev Esp Enferm Dig; 1998 Oct; 90(10):687-94. PubMed ID: 9824933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide does not prevent postoperative pancreatic fistula or mortality following Pancreaticoduodenectomy.
    Barnett SP; Hodul PJ; Creech S; Pickleman J; Arahna GV
    Am Surg; 2004 Mar; 70(3):222-6; discussion 227. PubMed ID: 15055845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial comparing somatostatin with octreotide in the prevention of complications after pancreatectomy.
    Closset J; Journe S; Mboti F; El Nakadi I; Gelin M
    Hepatogastroenterology; 2008; 55(86-87):1818-23. PubMed ID: 19102400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial.
    Hesse UJ; Meester D; Troisi R; Cathenis K; Lameire N; Hemptinne B
    Clin Transplant; 2005 Jun; 19(3):299-303. PubMed ID: 15877788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of pancreatic fistula following pancreaticoduodenectomy for periampullary cancer.
    Popiela T; Kedra B; Sierzega M; Gurda A
    Hepatogastroenterology; 2004; 51(59):1484-8. PubMed ID: 15362783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide inhibits pancreatic exocrine secretion and prevents pancreatoenterostomy leakage.
    Nakatsuka A; Yamaguchi K; Chijiiwa K; Tanaka M
    Int Surg; 2000; 85(2):124-9. PubMed ID: 11071328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide prophylaxis is not beneficial for biochemical activity and clinical severity of postoperative pancreatic fistula after pancreatic surgery.
    Droeser RA; Jeanmonod P; Schuld J; Moussavian MR; Schilling MK; Kollmar O
    Dig Surg; 2012; 29(6):484-91. PubMed ID: 23392293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide in the prevention of intra-abdominal complications following elective pancreatic resection: a prospective, multicenter randomized controlled trial.
    Suc B; Msika S; Piccinini M; Fourtanier G; Hay JM; Flamant Y; Fingerhut A; Fagniez PL; Chipponi J;
    Arch Surg; 2004 Mar; 139(3):288-94; discussion 295. PubMed ID: 15006886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Somatostatin prophylaxis following cephalic duodenopancreatectomy].
    Beguiristain A; Espí A; Balen E; Pardo F; Hernández Lizoaín JL; Alvarez Cienfuegos J
    Rev Esp Enferm Dig; 1995 Mar; 87(3):221-4. PubMed ID: 7742052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of somatostatin and its analogues in prevention of postoperative complications after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials.
    Zeng Q; Zhang Q; Han S; Yu Z; Zheng M; Zhou M; Bai J; Jin R
    Pancreas; 2008 Jan; 36(1):18-25. PubMed ID: 18192875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of postoperative pancreatic fistula resistant to octreotide therapy].
    Dobosz M; Dymecki D; Babicki A; Hać S; Gruca Z; Wajda Z
    Wiad Lek; 2001; 54(7-8):380-5. PubMed ID: 11641892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective administration of prophylactic octreotide during pancreaticoduodenectomy: a clinical and cost-benefit analysis in low- and high-risk glands.
    Vanounou T; Pratt WB; Callery MP; Vollmer CM
    J Am Coll Surg; 2007 Oct; 205(4):546-57. PubMed ID: 17903728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of prophylactic long-acting octreotide in high-risk patients undergoing pancreaticoduodenectomy.
    Graham JA; Johnson LB; Haddad N; Al-Kawas F; Carroll J; Jha R; Wong J; Maglaris D; Mertens S; Fishbein T
    Am J Surg; 2011 Apr; 201(4):481-5. PubMed ID: 21421102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trial.
    Berger AC; Howard TJ; Kennedy EP; Sauter PK; Bower-Cherry M; Dutkevitch S; Hyslop T; Schmidt CM; Rosato EL; Lavu H; Nakeeb A; Pitt HA; Lillemoe KD; Yeo CJ
    J Am Coll Surg; 2009 May; 208(5):738-47; discussion 747-9. PubMed ID: 19476827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary report of a prospective randomized study of octreotide in the treatment of severe acute pancreatitis.
    Paran H; Neufeld D; Mayo A; Shwartz I; Singer P; Kaplan O; Skornik Y; Klausner J; Freund U
    J Am Coll Surg; 1995 Aug; 181(2):121-4. PubMed ID: 7627383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review.
    Lai EC; Lau SH; Lau WY
    Arch Surg; 2009 Nov; 144(11):1074-80. PubMed ID: 19917946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intra-arterial octreotide on pancreatic texture: a randomized controlled trial.
    Belyaev O; Polle C; Herzog T; Munding J; Chromik AM; Meurer K; Tannapfel A; Bergmann U; Müller CA; Uhl W
    Scand J Surg; 2013; 102(3):164-70. PubMed ID: 23963030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy.
    You DD; Paik KY; Park IY; Yoo YK
    Asian J Surg; 2019 Feb; 42(2):458-463. PubMed ID: 30262436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic irrigation around a pancreaticojejunostomy for the treatment of a pancreatic fistula after a pancreaticoduodenectomy in patients with a risky pancreatic remnant.
    Nakano H; Asakura T; Sakurai J; Koizumi S; Asano T; Watanabe T; Otsubo T
    Hepatogastroenterology; 2008; 55(82-83):717-21. PubMed ID: 18613441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role octreotide in prevention of complications after pancreatoduodenal resections].
    Shatverian GA; Ratnikova NP; Mikhaĭlov IuE; Bedzhanian AL; Sidorov AN; Fisenko EP; Skipenko OG
    Khirurgiia (Mosk); 2004; (2):56-60. PubMed ID: 14997883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.